News

SyncThink Secures CE Mark for EYE-SYNC Digital Health Platform

Neurotechnology solution gains vital certification needed for EU expansion Palo Alto, CA – (August 10, 2022) – SyncThink, a next generation…

2 years ago

H1 Launches AI-Powered and Evidence-Based Interactions to Meet the Evolving Needs of Pharmaceutical and Biotech Medical Affairs Teams

New capabilities within H1’s HCP Universe platform empower corporate Medical Affairs and MSL teams to act faster and more effectively…

2 years ago

Ovia Health Solution Significantly Improves Preterm Birth Rates, Third-Party Validation Shows

Two-Year, In-Depth Analysis Suggests Ovia’s Platform Can Also Reduce Maternity Claims CostsBOSTON, Aug. 11, 2022 (GLOBE NEWSWIRE) -- A digital…

2 years ago

Panbela Announces First Patient Enrolled in its Aspire Trial Studying SBP-101 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Ductal Adenocarcinoma

Expects interim data by early 2024MINNEAPOLIS, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage…

2 years ago

Zealand Pharma Announces Financial Results for the First Half of 2022

Company Announcement No. 34 / 2022 Interim report for H1 2022 Zealand Pharma Announces Financial Results for the First Half…

2 years ago

Smart for Life Announces 171% Increase in Amazon Sales and Largest Prime Day in Its History

Company Provides Updates on its Amazon Initiatives; Continues its Expansion of Online Presence and OutreachMIAMI, Aug. 11, 2022 (GLOBE NEWSWIRE)…

2 years ago

Allied Corp Successfully Ships 1728kgs of Colombian-Grown Commercial Cannabis Flower to Switzerland

Allied Corp is the first company to successfully ship commercial cannabis flower from Colombia to an international market.Allied Corp has…

2 years ago

WIMI Hologram Academy: Simulated Driving System Based on Virtual Reality Experimental Scenarios

HONG KONG, Aug. 11, 2022 (GLOBE NEWSWIRE) -- WIMI Hologram Academy, working in partnership with the Holographic Science Innovation Center,…

2 years ago

Landos Biopharma Reports Second Quarter 2022 Results and Provides Business Update

Positive Top-Line Results From NX-13 Phase 1b Trial in Ulcerative Colitis Demonstrate a Favorable Safety and Tolerability Profile Across Range…

2 years ago

Monopar Therapeutics Reports Second Quarter 2022 Financial Results and Recent Program Developments

Validive® Phase 2b/3 VOICE Trial Continues Adding Sites in the U.S. and Europe and Enrolling Patients Toward Interim Analysis Anticipated…

2 years ago